| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |